BeOne Medicines (ONC) Other Non-Current Liabilities (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Other Non-Current Liabilities data on file, last reported at $82.0 million in Q1 2026.

• Quarterly Other Non-Current Liabilities rose 24.87% year-over-year to $82.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.0 million (up 24.87% YoY) and the FY2025 annual result came in at $80.2 million, up 20.24% from the prior year.
• Other Non-Current Liabilities advanced to $82.0 million in Q1 2026 per ONC's latest filing, from $80.2 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $180.5 million in Q4 2022 and bottomed at $42.0 million in Q3 2023.
• The 5-year median for Other Non-Current Liabilities is $51.5 million (2024), against an average of $63.5 million.
• The widest annual swing landed in 2022, when Other Non-Current Liabilities soared 232.77%; it then plunged 71.85% in 2023.
• Tracing ONC's Other Non-Current Liabilities over 5 years: stood at $180.5 million in 2022, then sank by 71.85% to $50.8 million in 2023, then surged by 31.34% to $66.7 million in 2024, then rose by 20.24% to $80.2 million in 2025, then climbed by 2.13% to $82.0 million in 2026.
• Per Business Quant, the three latest ONC Other Non-Current Liabilities figures stand at $82.0 million (Q1 2026), $80.2 million (Q4 2025), and $64.1 million (Q3 2025).

Peer Comparison